Skip to main content
Clinical Trials/CTIS2024-511719-40-00
CTIS2024-511719-40-00Active, not recruitingPhase 1

Efficay and safety of ampicillin and ceftriaxone continuous infusion versus intermittent infusion for the treatment of Enterococcus faecalis infective endocarditis (DOßLEI Study) - DOßLEI

Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla0 sites284 target enrollmentStarted: May 7, 2024Last updated:

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Enrollment
284

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 65+ (—)
Sex
All

Inclusion Criteria

  • Adult patients (18 years of age or older), Possible or definitive diagnosis of infective endocarditis due to Enterococcus faecalis according to the Duke-ISCVID criteria, Signed informed consent of patients

Exclusion Criteria

  • Allergy to penicillins or cephalosporins, Pregnancy and lactation, Polymicrobial infection including microorganisms different to E. faecalis

Investigators

Similar Trials